General market situation: European markets are mostly trading slightly higher during Thursday’s trading session. The German DAX on the cash market is hoverer, contracting almost 0.25% (the DE40 contract is down by 0.35%). Today, investors’ attention is turning to the US PPI data and the Hugo Boss quarterly report. Any information about the negotiations between the US, Ukraine and Russia may prove equally important.
On the broader European market, we are observing mixed investor sentiment. On the one hand, we are observing significant increases in the prices of mining and pharmaceutical stocks, and on the other, significant declines in the automotive sector. Source: xStation
The German DE40 index is losing 0.35% today intraday. The most important support for the index remains the 50-day EMA (blue line on the chart) and the support area of the consolidation zone at almost 21,230 points. Technically, DE40 is still maintaining a stable upward trend. Source: xStation
Corporate News:
Hugo Boss (BOSS.DE) shares are up 2.0% despite the apparel maker’s sales forecast for 2025 falling short of analysts’ estimates. On the other hand, the company’s management said sales in the Americas are expected to grow by low-single-digit percentages in 2025. The company is forecasting a significant improvement in profitability in fiscal 2025, supported by a continued focus on implementing cost efficiencies.
ANNUAL FORECAST
- Sales EUR 4.20bn to EUR 4.40bn, estimated EUR 4.44bn
- Ebit EUR 380m to EUR 440m, estimated EUR 416.7m
- Ebit margin 9% to 10%, estimated 9.48%
- Capital expenditure EUR 200m to EUR 250m
Q4 RESULTS
- Ebit EUR 126m, +4.1% y/y, estimated EUR 127.3m
- Net profit EUR 84m, -1.2% y/y, estimated EUR 83.8m
- Sales EUR 1.25b, +6.1% y/y, estimated EUR 1.2b
2024 RESULTS
- Ebit EUR 361m, -12% y/y, estimated EUR 361.2m EUR
- Dividend per share EUR 1.40 vs EUR 1.35 y/y, estimated EUR 1.20
- Sales EUR 4.31 billion, +2.6% y/y, estimated EUR 4.25 billion
Rheinmetall (RHM.DE) and Volkswagen (VOW1.DE) face new cooperation as VOW’s Osnabrück plant is refocused on armoured vehicle production.
Upgrades:
- Zealand Pharma upgraded to buy at SEB Equities; PT 850 kroner
Downgrades:
- BP downgraded to neutral at Grupo Santander; PT 460 pence
- Bilfinger downgraded to hold at HSBC; PT 73 euros
- Puma downgraded to hold at Stifel; PT 25 euros
- Puma downgraded to neutral at BNPP Exane; PT 25 euros
- Thales downgraded to maintain at Jefferies; PT 240 euros
Recommendation initiations:
- Dassault Aviation rated a new buy at Jefferies; PT 350 euros
- Hensoldt rated a new underperform at Jefferies; PT 55 euros
- Julius Baer reinstated a buy at Goldman; PT 77 Swiss francs
- Leonardo rated a new buy at Jefferies; PT 52 euros
- Rheinmetall rated a new buy at Jefferies; PT 1540 euros
Other news from individual DAX companies. Source: Bloomberg Financial LP
The material on this page does not constitute financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other specific needs. All information provided, including opinions, market research, mathematical results and technical analyzes published on the Website or transmitted To you by other means, it is provided for information purposes only and should in no way be construed as an offer or solicitation for a transaction in any financial instrument, nor should the information provided be construed as advice of a legal or financial nature on which any investment decisions you make should be based exclusively To your level of understanding, investment objectives, financial situation, or other specific needs, any decision to act on the information published on the Website or sent to you by other means is entirely at your own risk if you In doubt or unsure about your understanding of a particular product, instrument, service or transaction, you should seek professional or legal advice before trading. Investing in CFDs carries a high level of risk, as they are leveraged products and have small movements Often the market can result in much larger movements in the value of your investment, and this can work against you or in your favor. Please ensure you fully understand the risks involved, taking into account investments objectives and level of experience, before trading and, if necessary, seek independent advice.
